Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 16, 2024 - Issue
Submit an article Journal homepage
31
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective

Bjoern Schwander1 Department of Health Economics & Outcomes Research, AHEAD GmbH, Bietigheim-Bissingen, Baden-Württemberg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3869-8016
ORCID Icon,
Katharina Klesper2 Department of Health Economics & Epidemiology, ECON-EPI, Meerbusch, Nordrhein-Westfalen, Germany
,
Siegbert Rossol3 Medical Clinic, Krankenhaus Nordwest, Frankfurt a.M., Hessen, Germany
,
Ken Herrmann4 Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Nordrhein-Westfalen, Germany
&
York Francis Zoellner5 Department of Health Sciences, University of Applied Sciences Hamburg, Hamburg, Germany
Pages 483-492 | Received 06 Mar 2024, Accepted 17 May 2024, Published online: 05 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.